Recruitment open to Spevigo (spesolimab)

by | Feb 1, 2024 | News | 0 comments

We are now accepting patients on Spevigo (spesolimab). Spevigo is indicated for the treatment of flares in adult patients with generalised pustular psoriasis (GPP). BADBIR can accept registrations for patients with a GPP diagnosis.

Please see the eligibility page for full details of the treatments we currently recruit for.

0 Comments

Recent Comments